At Regional Cancer Care Associates (RCCA) in New Jersey, hematologist and oncologist Dr. Kenneth D. Nahum treats patients with blood disorders and cancers. Over the course of his three-decade career, Dr. Kenneth D. Nahum has cared for thousands of patients and has been involved in dozens of medical studies on conditions such as renal cell carcinoma (RCC).
Also known as kidney cancer, hypernephroma, and renal adenocarcinoma, RCC is the most common type of kidney cancer in adults. Due to its rapid growth, RCC frequently spreads to nearby organs and the lungs.
RCC most often affects men between the ages of 50 and 70 and is accompanied by symptoms that include fatigue, loss of appetite, a lump in the abdomen, and persistent pain in the side.
Doctors test for RCC by performing a physical exam for enlarged veins and lumps or swelling in the abdomen. To obtain a more accurate diagnosis, doctors may also have patients undergo additional tests, including a CT scan and complete blood count.
When tests reveal a diagnosis of RCC, the patient must undergo additional tests so doctors can know the stage. RCC stages range from one to four, with four being the most severe.
Depending on the stage of the cancer and the patient’s overall health, doctors will recommend at least one of five treatment options: surgery, chemotherapy, radiation therapy, targeted therapy, or immunotherapy. These treatments are designed to remove the cancer cells and leverage the body’s defenses to fight the growth of cancer cells.